{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T03:20:36Z","timestamp":1791516036937,"version":"4.3.4"},"reference-count":31,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2024,1,22]],"date-time":"2024-01-22T00:00:00Z","timestamp":1705881600000},"content-version":"vor","delay-in-days":21,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ascpt.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Clinical Translational Sci"],"published-print":{"date-parts":[[2024,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Intestinal P\u2010glycoprotein (P\u2010gp) activity plays a crucial role in modulating the oral bioavailability of its substrates. Fexofenadine has commonly been used as a P\u2010gp probe, although it is important to note the involvement of other drug transporters like, OATP1B1, OATP1B3, and OATP2B1. In\u00a0vitro studies demonstrated an upregulation of P\u2010gp protein in response to exposure to pregnancy\u2010related hormones. The objective of this study was to investigate how intestinal P\u2010gp activity is impacted by menopausal status. This study sampled fexofenadine plasma concentrations over 0\u201312\u2009h after probe drug administration from two groups of patients with breast cancer: premenopausal (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u200920) and postmenopausal (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u200920). Fexofenadine plasma concentrations were quantified using liquid\u2010chromatography tandem mass spectrometry. Area under the plasma concentration\u2010time curve from zero to infinity (AUC\n                    <jats:sub>inf<\/jats:sub>\n                    ) was calculated through limited sampling strategies equation. Multiple linear regression was applied on AUC\n                    <jats:sub>inf<\/jats:sub>\n                    , maximum plasma concentration (\n                    <jats:italic>C<\/jats:italic>\n                    <jats:sub>max<\/jats:sub>\n                    ), and time to\n                    <jats:italic>C<\/jats:italic>\n                    <jats:sub>max<\/jats:sub>\n                    . Postmenopausal patients showed a significant increase in\n                    <jats:italic>C<\/jats:italic>\n                    <jats:sub>max<\/jats:sub>\n                    (geometric mean and 95% confidence interval [CI] 143.54, 110.95\u2013176.13 vs. 223.54\u2009ng\/mL, 161.02\u2013286.06 and in AUC\n                    <jats:sub>inf<\/jats:sub>\n                    685.55, 534.98\u2013878.50 vs. 933.54\u2009ng\u00b7h\/mL 735.45\u20131184.99) compared to premenopausal patients. The carriers of the ABCB1 3435 allele T displayed higher\n                    <jats:italic>C<\/jats:italic>\n                    <jats:sub>max<\/jats:sub>\n                    values of 166.59 (95% CI: 129.44\u2013214.39) compared to the wild type at 147.47\u2009ng\/mL (95% CI: 111.91\u2013194.34,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.02). In postmenopausal individuals, the decrease in P\u2010gp activity of ~40% may lead to an increased plasma exposure of orally administered P\u2010gp substrates.\n                  <\/jats:p>","DOI":"10.1111\/cts.13713","type":"journal-article","created":{"date-parts":[[2024,1,16]],"date-time":"2024-01-16T04:15:08Z","timestamp":1705378508000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Intestinal P\u2010gp activity is reduced in postmenopausal women under breast cancer therapy"],"prefix":"10.1111","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6414-5220","authenticated-orcid":false,"given":"Joao Paulo B.","family":"Ximenez","sequence":"first","affiliation":[{"name":"School of Pharmaceutical Sciences of Ribeirao Preto University of Sao Paulo  Ribeirao Preto Sao Paulo Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3619-0582","authenticated-orcid":false,"given":"Jurandyr Moreira","family":"de Andrade","sequence":"additional","affiliation":[{"name":"Ribeirao Preto Medical School University of Sao Paulo  Ribeirao Preto Sao Paulo Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana","family":"Rocha","sequence":"additional","affiliation":[{"name":"School of Pharmaceutical Sciences of Ribeirao Preto University of Sao Paulo  Ribeirao Preto Sao Paulo Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3491-3396","authenticated-orcid":false,"given":"Eduardo","family":"Barbosa\u00a0Coelho","sequence":"additional","affiliation":[{"name":"Ribeirao Preto Medical School University of Sao Paulo  Ribeirao Preto Sao Paulo Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1115-8319","authenticated-orcid":false,"given":"Guilherme","family":"Suarez\u2010Kurtz","sequence":"additional","affiliation":[{"name":"Division of Clinical Research and Technological Development National Cancer Institute of Brazil  Rio de Janeiro RJ Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0074-4953","authenticated-orcid":false,"given":"Vera Lucia","family":"Lanchote","sequence":"additional","affiliation":[{"name":"School of Pharmaceutical Sciences of Ribeirao Preto University of Sao Paulo  Ribeirao Preto Sao Paulo Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2024,1,22]]},"reference":[{"key":"e_1_2_11_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2021.05.014"},{"key":"e_1_2_11_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/bph.12362"},{"key":"e_1_2_11_4_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.104.002469"},{"key":"e_1_2_11_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-9236(96)90112-5"},{"key":"e_1_2_11_6_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13318-015-0285-2"},{"key":"e_1_2_11_7_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.1004010"},{"key":"e_1_2_11_8_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.00397.2005"},{"key":"e_1_2_11_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/0531-5565(94)90023-X"},{"key":"e_1_2_11_10_1","doi-asserted-by":"publisher","DOI":"10.1097\/FPC.0b013e32834300cc"},{"key":"e_1_2_11_11_1","doi-asserted-by":"publisher","DOI":"10.1067\/mcp.2001.113697"},{"key":"e_1_2_11_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clpt.2005.04.012"},{"key":"e_1_2_11_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clpt.2004.08.026"},{"key":"e_1_2_11_14_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2008.102"},{"key":"e_1_2_11_15_1","doi-asserted-by":"publisher","DOI":"10.1186\/s40360-019-0358-y"},{"key":"e_1_2_11_16_1","doi-asserted-by":"publisher","DOI":"10.1002\/bmc.3114"},{"key":"e_1_2_11_17_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.00022"},{"key":"e_1_2_11_18_1","doi-asserted-by":"publisher","DOI":"10.2165\/11318000-000000000-00000"},{"key":"e_1_2_11_19_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2014.83"},{"key":"e_1_2_11_20_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.718"},{"key":"e_1_2_11_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2007.02899.x"},{"key":"e_1_2_11_22_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.107.019083"},{"key":"e_1_2_11_23_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1099-081X(199810)19:7<455::AID-BDD130>3.0.CO;2-W"},{"key":"e_1_2_11_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clpt.2004.10.005"},{"key":"e_1_2_11_25_1","doi-asserted-by":"publisher","DOI":"10.1067\/mcp.2002.121152"},{"key":"e_1_2_11_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2013.10.003"},{"key":"e_1_2_11_27_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1995.59"},{"key":"e_1_2_11_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2023.05.021"},{"key":"e_1_2_11_29_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01201-17"},{"key":"e_1_2_11_30_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.97.7.3473"},{"key":"e_1_2_11_31_1","doi-asserted-by":"publisher","DOI":"10.1067\/mcp.2001.117412"},{"key":"e_1_2_11_32_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11095-004-9004-4"}],"container-title":["Clinical and Translational Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ascpt.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/cts.13713","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,24]],"date-time":"2024-01-24T13:41:51Z","timestamp":1706103711000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascpt.onlinelibrary.wiley.com\/doi\/10.1111\/cts.13713"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["10.1111\/cts.13713"],"URL":"https:\/\/doi.org\/10.1111\/cts.13713","archive":["Portico"],"relation":{},"ISSN":["1752-8054","1752-8062"],"issn-type":[{"value":"1752-8054","type":"print"},{"value":"1752-8062","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"2023-08-11","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-12-07","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-01-22","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e13713"}}